Interventional treatment of resistant hypertension by the use of renal artery denervation is nearer with the publication of the latest clinical trial: Simplicity HTN-2 at the recent American Heart Association meeting in Chicago. In this trial, renal artery denervation...
The recently released results of the DEFINE trial showed that patients taking anacetrapib, from a new class of medication (CETP inhibitors) reduced their LDL cholesterol (bad cholesterol) by approximately 40%, and raised their HDL cholesterol (good) by 140%. This...
Intellectual Ventures (www.intellectualventures.com) is a truly amazing company. Founded by former Microsoft Chief Technology Officer Nathan Myhrvold, the company gathers some smart people who sit down and hash out ideas and patents in diverse fields of interests....
Recent Comments